Skip to main content

Month: May 2023

Vaisala Oyj: SHARE REPURCHASE 12.5.2023

VAISALA CORPORATION STOCK EXCHANGE RELEASE, 12.5.2023          VAISALA CORPORATION: SHARE REPURCHASE 12.5.2023       In the Helsinki Stock Exchange         Trade date           12.5.2023  Bourse trade         Buy  Share                  VAIAS  Amount             3 173 SharesAverage price/ share    41,8808 EURTotal cost            132 887,78 EUR          Vaisala Corporation now holds a total of 145 300 sharesincluding the shares repurchased on 12.5.2023            On behalf of Vaisala Corporation         Nordea Bank Oyj         Janne Sarvikivi           Sami Huttunen                 Additional information     Paula Liimatta    tel +358 9 8949 2020,     ir@vaisala.com              www.vaisala.com              ​​​​​Vaisala is a...

Continue reading

Disclosure of voting rights at AGM in Vistin Pharma ASA

In relation to the Annual General Meeting in Vistin Pharma ASA on the 22nd of May, the Company’s Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total of 3 905 611 shares in the Company at the AGM, corresponding to 8.81% of the total number of votes and shares in the Company. Together with the 12 575 000 shares held by Øyvin Brøymer through Intertrade Shipping AS, he will represent a total of 16 480 611 votes at the AGM, corresponding to a total of 37,16% of the total number of shares and votes in the Company. The proxies are only valid for the AGM and will lapse thereafter.

Continue reading

Results of additional issuance – RIKB 26 1015 – RIKB 42 0217

As stated in paragraph 6 in General Terms of Auction for Treasury bonds, the Government Debt Management offered the equivalent of 10% of the nominal value sold in the auction 10. May, at the price of accepted bids.Series RIKB 26 1015 RIKB 42 0217ISIN IS0000034874 IS0000033884Additional issuance (nominal) 178,000,000 289,000,000Settlement date 05/15/2023 05/15/2023Total outstanding (nominal) 32,523,000,000 48,187,000,000

Continue reading

CORRECTION – InvestmentPitch Media Video Discusses Etruscus Resources and its Newly Started 2023 Drill Program at its Lewis Property in Newfoundland

VANCOUVER, British Columbia, May 12, 2023 (GLOBE NEWSWIRE) — Etruscus Resources Corp. (CSE:ETR) (FSE:ERR) (OTCPink:ETRUF) has started its 2023 drill program at its Lewis Property in Newfoundland. The road accessible Lewis property is located 5 km south of the Trans Canada Highway in the Gander Gold Belt, approximately 10 km west of New Found Gold’s Keats Zone discovery. A Media Snippet accompanying this announcement is available by clicking on the image or link below:For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company along with video comment from Carl Ryan, Geologist and Project lead on the project. The video is available for viewing on “InvestmentPitch” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and...

Continue reading

INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF APRIL 30, 2023(1)

REGULATED RELEASE INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SAAS OF APRIL 30, 2023(1) Paris – May 12, 2023 NUMBER OF SHARES AS OF APRIL 30, 2023Date 04/30/2023Company name KlépierreTrading place Euronext Paris (Compartment A)Mnemonic LISymbols EPA:LI / LI:FP / LOIM.PAISIN FR0000121964Total number of shares 286,861,172Total number of voting rights  Number of theoretical voting rights(2) 286,861,172Number of exercisable voting rights(3)  285,425,632AGENDA  July 7, 2023 Ex-dividend date for the final paymentJuly 11, 2023August 1, 2023 Final dividend paymentFirst-half 2023 earnings (after market close)INVESTOR RELATIONS CONTACTS    Paul Logerot, Group Head of IR and financial communication +33 (0)7 50 66 05 63 — paul.logerot@klepierre.comTanguy Phelippeau, IR Officer...

Continue reading

McPhy Energy: Monthly report relating to the total number of voting rights and outstanding shares (as of April 30, 2023)

Translation for information purposes only Monthly information relating to the total number of voting rights and outstanding sharesIn accordance with articles L. 233-8-II of the French Commercial Code and 223-16 of the Autorité des Marchés Financiers General Regulation Reporting company:Corporate name: McPhy Energy Public Limited company (société anonyme) with Board of Directors Registered office: 79 rue Général Mangin, 38100 Grenoble Registered under number 502 205 917 R.C.S. Grenoble Euronext Paris Compartment B (ISIN code: FR0011742329 – MCPHY)Date Total number of outstanding shares Total number of voting rights*Gross Net30.04.2023 27,959,095 29,257,708 28,088,942* Total number of voting rights (i) “gross” calculated on the basis of all the shares to which voting rights...

Continue reading

Touax: Availability of documents Annual shareholders’ meeting of June 14th, 2023

REGULATED INFORMATION                Paris, 12 May 2023 5:45 PM YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Availability of documents Annual shareholders’ meeting of June 14th, 2023 TOUAX informs its shareholders that its combined Annual Shareholders’ Meeting will be held on Wednesday June 14, 2023 at 3:00 p.m. at Châteauform’ Learning Lab La Défense, 40 passage de l’Arche, 92800 Puteaux, France. The official meeting announcements have been published in the BALO (Bulletin des Annonces Légales Obligatoires) on May 5, 2023. Pursuant to Article 221-1 of the “Règlement général” of the “Autorité des marchés financiers”, information mentioned in Article R.225-83 of the French Commercial Code is already available to shareholders, in accordance with the applicable French laws and regulations, and under the following...

Continue reading

Mithra Pharmaceuticals – Payment of the interests of the Highbridge/Whitebox loans Information on the total number of voting rights (denominator)

Payment of the interests of the Highbridge/Whitebox loans Information on the total number of voting rights (denominator) Liege, Belgium, 12 May 2023 – 17:50 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra“), a company dedicated to Women’s Health, today announces that, the third quarterly interests of the loan facility concluded with funds managed by Highbridge Capital Management, LLC (“Highbridge“) and funds managed by Whitebox Advisors, LLC (“Whitebox“, and together with Highbridge, each a “Lender”), was paid through contribution in kind against the issuance of new shares for an aggregate amount of EUR 641,289.61 through the issuance of 285,409 new shares at an issue price of EUR 2.25. On 8th August 2022, the Company and the Lenders entered into a three-year...

Continue reading

DCAC announces adjournment to EGM and Class Meetings, updates to Shareholder Circular and updates to proxy forms

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. ANY FAILURE TO COMPLY WITH THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS. THIS PRESS RELEASE CONTAINS INFORMATION THAT QUALIFIES OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EU MARKET ABUSE REGULATION. DISRUPTIVE CAPITAL ACQUISITION COMPANY LIMITED(“DCAC” or the “Company”)   in respect ofDCAC Shareholders (ISIN Code GG00BMB5XZ39),DCAC Public Warrant Holders (ISIN Code GG00BMB5XY22) DCAC announces adjournment to EGM and Class Meetings, updates to Shareholder Circular and updates to proxy forms                         ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.